Which is performing better right now, JNJ or TMO?

Over the past month JNJ is -4.4% and TMO is +6.4%, so TMO is ahead on that window. Year to date the figures are +23.5% for JNJ and +19.1% for TMO.

What are the key levels for JNJ and TMO?

JNJ: resistance $265.23, support $251.08; TMO: resistance $696.49, support $650.00. Levels come from recent swing zones and round numbers, recomputed daily.

When do JNJ and TMO report next?

JNJ: 2026-10-13. TMO: 2026-10-21. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.

What does the JNJ/TMO ratio mean?

It is simply JNJ's price divided by TMO's — 0.3704 today. When the ratio rises, JNJ is outperforming; when it falls, TMO is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

JNJ vs TMO

Johnson & Johnson against Thermo Fisher Scientific — live side-by-side technical comparison.

Prices as of 2026-10-16T20:00:02+00:00 UTC · updates daily

Who leads right now

TMO leads 3 of the 5 windows we measure — over 1 month JNJ is -4.4% and TMO +6.4%; over year to date JNJ is +23.5% and TMO +19.1%. The JNJ/TMO price ratio stands at 0.3704, below its 50-day average of 0.4177, and below the 200-day average of 0.4514. A ratio above its own average means JNJ is gaining on TMO; on this reading the recent edge belongs to TMO.

Performance side by side

	JNJ	TMO
Price	$255.56	$690.00
1 day	+0.9%lead	-0.9%
5 days	-2.2%	+4.9%lead
1 month	-4.4%	+6.4%lead
6 months	+9.0%	+33.7%lead
Year to date	+23.5%lead	+19.1%
52-week position	74% of range	95% of range
52-week range	$184.66–$281.07	$435.27–$704.00
vs 50-day average	below $265.23	above $636.69
vs 200-day average	above $244.12	above $547.32
RSI (14)	36	54
Next earnings	2026-10-13	2026-10-21

Where each one stands

JNJ — Johnson & Johnson

JNJ trades at $255.56, below its 50-day average of $265.23, and above the 200-day at $244.12. It sits at 74% of its 52-week range ($184.66–$281.07); 14-day RSI is 36, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $265.23 (3.8% away) and the first support below is $251.08 (1.8% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.

TMO — Thermo Fisher Scientific

TMO trades at $690.00, above its 50-day average of $636.69, and above the 200-day at $547.32. It sits at 95% of its 52-week range ($435.27–$704.00); 14-day RSI is 54, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $696.49 (0.9% away) and the first support below is $650.00 (5.8% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

Which one moves harder

TMO is the more volatile of the two — an average session moves it 2.9% against 2.5% for JNJ, so an identical position size carries roughly 1.2× the daily risk.

What would change the picture

The comparison turns on those levels: JNJ clearing $265.23 or losing $251.08; TMO clearing $696.49 or losing $650.00. Until one of them gives way, the relative reading above stands.

Questions people ask about JNJ vs TMO

Which is performing better right now, JNJ or TMO?: Over the past month JNJ is -4.4% and TMO is +6.4%, so TMO is ahead on that window. Year to date the figures are +23.5% for JNJ and +19.1% for TMO.
Is JNJ or TMO more volatile?: TMO is the more volatile of the two — an average session moves it 2.9% against 2.5% for JNJ, so an identical position size carries roughly 1.2× the daily risk.
What are the key levels for JNJ and TMO?: JNJ: resistance $265.23, support $251.08; TMO: resistance $696.49, support $650.00. Levels come from recent swing zones and round numbers, recomputed daily.
When do JNJ and TMO report next?: JNJ: 2026-10-13. TMO: 2026-10-21. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the JNJ/TMO ratio mean?: It is simply JNJ's price divided by TMO's — 0.3704 today. When the ratio rises, JNJ is outperforming; when it falls, TMO is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.